Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability

  1. Mark R Sullivan
  2. Laura V Danai
  3. Caroline A Lewis
  4. Sze Ham Chan
  5. Dan Y Gui
  6. Tenzin Kunchok
  7. Emily A Dennstedt
  8. Matthew G Vander Heiden  Is a corresponding author
  9. Alexander Muir  Is a corresponding author
  1. Massachusetts Institute of Technology, United States
  2. University of Chicago, United States

Abstract

Cancer cell metabolism is heavily influenced by microenvironmental factors, including nutrient availability. Therefore, knowledge of microenvironmental nutrient levels is essential to understand tumor metabolism. To measure the extracellular nutrient levels available to tumors, we utilized quantitative metabolomics methods to measure the absolute concentrations of >118 metabolites in plasma and tumor interstitial fluid, the extracellular fluid that perfuses tumors. Comparison of nutrient levels in tumor interstitial fluid and plasma revealed that the nutrients available to tumors differ from those present in circulation. Further, by comparing interstitial fluid nutrient levels between autochthonous and transplant models of murine pancreatic and lung adenocarcinoma, we found that tumor type, anatomical location and animal diet affect local nutrient availability. These data provide a comprehensive characterization of the nutrients present in the tumor microenvironment of widely used models of lung and pancreatic cancer and identify factors that influence metabolite levels in tumors.

Data availability

Source data files detailing the concentrations of each metabolite in each sample are included for all figures. We have also deposited this information and the raw mass spectra in Metabolomics Workbench (http://www.metabolomicsworkbench.org/) as project ID: PR000750.

The following data sets were generated

Article and author information

Author details

  1. Mark R Sullivan

    Department of Biology, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    No competing interests declared.
  2. Laura V Danai

    Department of Biology, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    Laura V Danai, has applied for patents for therapeutic strategies to target cancer metabolism.(US Patent App. 15/890,220).
  3. Caroline A Lewis

    Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1787-5084
  4. Sze Ham Chan

    Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    No competing interests declared.
  5. Dan Y Gui

    Department of Biology, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    Dan Y Gui, has applied for patents for therapeutic strategies to target cancer metabolism.(US Patent App. 15/890,220).
  6. Tenzin Kunchok

    Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    No competing interests declared.
  7. Emily A Dennstedt

    Department of Biology, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    No competing interests declared.
  8. Matthew G Vander Heiden

    Department of Biology, Massachusetts Institute of Technology, Cambridge, United States
    For correspondence
    mvh@mit.edu
    Competing interests
    Matthew G Vander Heiden, has applied for patents for therapeutic strategies to target cancer metabolism. (US Patent App. 15/890,220). Also on the scientific advisory board of Agios Pharmaceuticals, Aeglea Biotherapeutics, and Auron Therapeutics, which seek to exploit altered metabolism for therapy. Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6702-4192
  9. Alexander Muir

    Ben May Department for Cancer Research, University of Chicago, Chicago, United States
    For correspondence
    amuir@uchicago.edu
    Competing interests
    Alexander Muir, has applied for patents for therapeutic strategies to target cancer metabolism.(US Patent App. 15/890,220).
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3811-3054

Funding

National Cancer Institute (R01CA168653)

  • Matthew G Vander Heiden

National Cancer Institute (F32CA210421)

  • Laura V Danai
  • Alexander Muir

Stand Up To Cancer

  • Mark R Sullivan
  • Laura V Danai
  • Dan Y Gui
  • Matthew G Vander Heiden
  • Alexander Muir

Howard Hughes Medical Institute

  • Mark R Sullivan
  • Laura V Danai
  • Dan Y Gui
  • Matthew G Vander Heiden
  • Alexander Muir

Ludwig Institute for Cancer Research

  • Mark R Sullivan
  • Laura V Danai
  • Dan Y Gui
  • Matthew G Vander Heiden
  • Alexander Muir

Lustgarten Foundation

  • Mark R Sullivan
  • Laura V Danai
  • Dan Y Gui
  • Matthew G Vander Heiden
  • Alexander Muir

Koch Institute for Integrative Cancer Research (Koch Institute Graduate Fellowship)

  • Mark R Sullivan

National Cancer Institute (R01CA201276)

  • Matthew G Vander Heiden

National Cancer Institute (P30CA1405141)

  • Matthew G Vander Heiden

National Cancer Institute (F32CA213810)

  • Laura V Danai
  • Alexander Muir

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals. All animals experiments were performed using protocols (#1115-110-18) that were approved by the MIT Committee on Animal Care (IACUC). All surgeries were performed using isoflurane anesthesia administered by vaporizer and every effort was made to minimize suffering.

Reviewing Editor

  1. Ralph DeBerardinis, UT Southwestern Medical Center, United States

Version history

  1. Received: December 10, 2018
  2. Accepted: April 4, 2019
  3. Accepted Manuscript published: April 16, 2019 (version 1)
  4. Version of Record published: May 10, 2019 (version 2)

Copyright

© 2019, Sullivan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 17,558
    Page views
  • 2,935
    Downloads
  • 280
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mark R Sullivan
  2. Laura V Danai
  3. Caroline A Lewis
  4. Sze Ham Chan
  5. Dan Y Gui
  6. Tenzin Kunchok
  7. Emily A Dennstedt
  8. Matthew G Vander Heiden
  9. Alexander Muir
(2019)
Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability
eLife 8:e44235.
https://doi.org/10.7554/eLife.44235

Share this article

https://doi.org/10.7554/eLife.44235

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Kristian Davidsen, Jonathan S Marvin ... Lucas B Sullivan
    Research Article

    Intracellular levels of the amino acid aspartate are responsive to changes in metabolism in mammalian cells and can correspondingly alter cell function, highlighting the need for robust tools to measure aspartate abundance. However, comprehensive understanding of aspartate metabolism has been limited by the throughput, cost, and static nature of the mass spectrometry (MS)-based measurements that are typically employed to measure aspartate levels. To address these issues, we have developed a green fluorescent protein (GFP)-based sensor of aspartate (jAspSnFR3), where the fluorescence intensity corresponds to aspartate concentration. As a purified protein, the sensor has a 20-fold increase in fluorescence upon aspartate saturation, with dose-dependent fluorescence changes covering a physiologically relevant aspartate concentration range and no significant off target binding. Expressed in mammalian cell lines, sensor intensity correlated with aspartate levels measured by MS and could resolve temporal changes in intracellular aspartate from genetic, pharmacological, and nutritional manipulations. These data demonstrate the utility of jAspSnFR3 and highlight the opportunities it provides for temporally resolved and high-throughput applications of variables that affect aspartate levels.

    1. Biochemistry and Chemical Biology
    Chi-Ning Chuang, Hou-Cheng Liu ... Ting-Fang Wang
    Research Article

    Serine(S)/threonine(T)-glutamine(Q) cluster domains (SCDs), polyglutamine (polyQ) tracts and polyglutamine/asparagine (polyQ/N) tracts are Q-rich motifs found in many proteins. SCDs often are intrinsically disordered regions that mediate protein phosphorylation and protein-protein interactions. PolyQ and polyQ/N tracts are structurally flexible sequences that trigger protein aggregation. We report that due to their high percentages of STQ or STQN amino acid content, four SCDs and three prion-causing Q/N-rich motifs of yeast proteins possess autonomous protein expression-enhancing activities. Since these Q-rich motifs can endow proteins with structural and functional plasticity, we suggest that they represent useful toolkits for evolutionary novelty. Comparative Gene Ontology (GO) analyses of the near-complete proteomes of 26 representative model eukaryotes reveal that Q-rich motifs prevail in proteins involved in specialized biological processes, including Saccharomyces cerevisiae RNA-mediated transposition and pseudohyphal growth, Candida albicans filamentous growth, ciliate peptidyl-glutamic acid modification and microtubule-based movement, Tetrahymena thermophila xylan catabolism and meiosis, Dictyostelium discoideum development and sexual cycles, Plasmodium falciparum infection, and the nervous systems of Drosophila melanogaster, Mus musculus and Homo sapiens. We also show that Q-rich-motif proteins are expanded massively in 10 ciliates with reassigned TAAQ and TAGQ codons. Notably, the usage frequency of CAGQ is much lower in ciliates with reassigned TAAQ and TAGQ codons than in organisms with expanded and unstable Q runs (e.g. D. melanogaster and H. sapiens), indicating that the use of noncanonical stop codons in ciliates may have coevolved with codon usage biases to avoid triplet repeat disorders mediated by CAG/GTC replication slippage.